СИНДРОМ ПОСТУРАЛЬНОЙ ОРТОСТАТИЧЕСКОЙ ТАХИКАРДИИ
Аннотация
Об авторах
Д. В. ДупляковРоссия
О. В. Горбачева
Россия
Г. А. Головина
Россия
Список литературы
1. Grubb BP, Kanjwal Y, Kosinski DJ. The postural tachycardia syndrome: a concise guide to diagnosis and management // J Cardiovasc Electrophysiol 2006; 17: 108-12.
2. Stewart JM, Medow MS, Montgomery LD. Local vascular responses affecting blood flow in postural tachycardia syndrome // Am J Physiol 2003; 285: H2749-56.
3. Stewart JM, Weldon A. Vascular perturbations in the chronic orthostatic intolerance of the postural orthostatic tachycardia syndrome // J Appl Physiol 2000; 89: 1505-12.
4. Thieben MJ, Sandroni P, Sletten DM et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience // Mayo Clin Proc 2007; 82: 308-13.
5. Raj SR. The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management // Indian Pacing Electrophysiol J 2006; 6: 84-99.
6. Low PA, Opfer-Gehrking TL, Textor SC et al. Postural tachycardia syndrome (POTS) //Neurology 1995; 45: S19-25.
7. Bonyhay I, Freeman R. Sympathetic neural activity, sex dimorphism, and postural tachycardia syndrome // Ann Neurol 2007; 61: 332-9.
8. Stewart JM. Chronic orthostatic intolerance and the postural tachycardia syndrome (POTS) // J Pediatr 2004; 145: 725-30.
9. Kanjwal Y, Kosinski D, Grubb BP. The postural orthostatic tachycardia syndrome: definitions, diagnosis, and management // Pacing Clin Electrophysiol 2003; 26: 1747-57.
10. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia // Neurology 1993; 43: 132-7.
11. Vernino S, Low PA, Fealey RD et al. Autoantbodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies // N Engl J Med 2000; 343: 847-55.
12. Furlan R, Jacob G, Snell M et al. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control // Circulation 1998; 98: 2154-9.
13. Broskey J, Sharp MK. Evaluation of mechanisms of postflight orthostatic intolerance with a simple cardiovascular system model // Ann Biomed Eng 2007; 35: 1800 -11.
14. Mano T. Autonomic neural functions in space // Curr Pharm Biotechnol 2005; 6: 319-24.
15. Stewart JM. Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects // Circulation 2002; 105: 2274-81.
16. Jacob G, Costa F, Shannon JR et al.The neuropathic postural tachycardia syndrome // New Engl J Med 2000; 343: 1008-14.
17. Streeten DH. Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs // J Clin Invest 1990; 86: 1582-8.
18. Shannon JR, Flattem NL, Jordan J et al.Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency // N Engl J Med 2000; 342: 541-9.
19. Raj SR, Biaggioni I, Yamhure PC et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome // Circulation 2005; 111: 1574-82.
20. Stewart JM. Microvascular filtration is increased in postural tachycardia syndrome // Circulation 2003; 107: 2816-22.
21. Jacob G, Robertson D, Mosqueda-Garcia R et al. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system // Am J Med 1997; 103: 128-33.
22. Schondorf R, Benoit J, Stein R. Cerebral autoregulation in orthostatic intolerance // Ann N Y Acad Sci 2001; 940: 514-26.
23. Novak V, Spies JM, Novak P et al. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance // Stroke 1998; 29: 1876-81.
24. Stewart JM, Gewitz MH, Weldon A et al. Orthostatic intolerance in adolescent chronic fatigue syndrome // Pediatrics 1999; 103: 116-21.
25. Stewart JM. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion // Pediatr Res 2000; 48: 218-26.
26. Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system // Am J Med 1997; 102: 357-64.
27. Jones JF, Nicholson A, Nisenbaum R et al. Orthostatic instability in a population-based study of chronic fatigue syndrome // Am J Med 2005; 118: 1415.
28. De Lorenzo F, Hargreaves J, Kakkar VV. Possible relationship between chronic fatigue and postural tachycardia syndromes // Clin Auton Res 1996; 6: 263-4.
29. Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome // Q J Med 2008; 101(12): 961-5.
30. Lee RJ, Shinbane JS. Inappropriate sinus tachycardia. Diagnosis and treatment // Cardiol Clin 1997; 15: 599-605.
31. Still AM, Raatikainen P, Ylitalo A et al. Prevalence, characteristics and natural course of inappropriate sinus tachycardia // Europace 2005; 7: 104 -12.
32. Brady PA, Low PA, Shen WK. Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes // Pacing Clin Electrophysiol 2005; 28: 1112-21.
33. Bauernfeind RA, Amat YLF, Dhingra RC et al. Chronic nonparoxysmal sinus tachycardia in otherwise healthy persons // Ann Intern Med 1979; 91: 702-10.
34. Leon H, Guzman JC, Kuusela T et al. Impaired baroreflex gain in patients with inappropriate sinus tachycardia // J Cardiovasc Electrophysiol 2005; 16: 64-8.
35. Morillo CA, Klein GJ, Thakur RK et al. Mechanism of ‘inappropriate’ sinus tachycardia. Role of sympathovagal balance// Circulation 1994; 90: 873-7.
36. Man KC, Knight B, Tse HF et al. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping // J Am Coll Cardiol 2000; 35: 451-7.
37. Shen WK, Low PA, Jahangir A et al. Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrom // Pacing Clin Electrophysiol 2001; 24: 217-30.
38. Masuki S, Eisenach JH, Johnson CP et al. Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety // J Appl Physiol 2007; 102: 896-903.
39. Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA. Postural tachycardia syndrome: clinical features and follow-up study // Mayo Clin Proc 1999; 74: 1106-10.
40. Grubb BP, Kosinski DJ, Boehm K, Kip K. The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing // Pacing Clin Electrophysiol 1997; 20: 2205-12.
41. Bush VE, Wight VL, Brown CM, Hainsworth R. Vascular responses to orthostatic stress in patients with postural tachycardia syndrome (POTS), in patients with low orthostatic tolerance, and in asymptomatic controls // Clin Auton Res 2000; 10: 279-84.
42. Hajdinjak M, Harris S, Corridan M. Diagnosing postural tachycardia syndrome: head-up tilt or standing? // Clin Auton Res 2006; 16: 137-192.
43. Jacob G, Shannon JR, Black B et al. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia // Circulation 1997; 96: 575-80.
44. Brignole M, Alboni P, Benditt DG et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004 // Europace 2004; 6: 467-537.
45. Molhoek GP, Wesseling KH, Settels JJ et al. Evaluation of the Penaz servo-plethysmo-manometer for the continuous, non-invasive measurement of finger blood pressure // Basic Res Cardiol 1984; 79: 598-609.
46. Raj SR, Robertson D. Blood volume perturbations in the postural tachycardia syndrome // Am J Med Sci 2007; 334: 57-60.
47. Shannon JR, Diedrich A, Biaggioni I. et al. Water drinking as a treatment for orthostatic syndromes // Am J Med 2002; 112: 355-60.
48. Winker R, Barth A, Bidmon D et al. ndurance exercise training in orthostatic intolerance: a randomized, controlled trial // Hypertension 2005; 45: 391-8.
49. Davies B, Bannester R, Sever P, Wilcox C. The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone // Br J Clin Pharmacol 1979; 8: 253-60.
50. Freitas J, Santos R, Azevedo E et al. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone // Clin Auton Res 2000; 10: 293-9.
51. Gordon VM, Opfer-Gehrking TL, Novak V, Low PA. Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome // Clin Auton Res 2000; 10: 29-33.
52. Hoeldtke RD, Bryner KD, Hoeldtke ME, Hobbs G. Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine // Clin Auton Res 2006; 16: 390-5.
53. Stewart JM, Munoz J, Weldon A. Clinical and physiological effects of an acute alpha-1 adrenergic agonist and a beta-1 adrenergic antagonist in chronic orthostatic intolerance // Circulation 2002; 106: 2946-54.
54. Sumiyoshi M, Nakata Y, Mineda Y et al. Analysis of heart rate variability during head-up tilt testing in a patient with idiopathic postural orthostatic tachycardia syndrome (POTS) // Jpn Circ J 1999; 63: 496-8.
55. Gaffney FA, Lane LB, Pettinger W, Blomqvist CG. Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia // Chest 1983; 83: 436-8.
56. Shibao C, Arzubiaga C, Roberts LJ II et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders // Hypertension 2005; 45: 385-90.
57. Singer W, Opfer-Gehrking TL, Nickander KK et al. Acetylcholinesterase inhibition in patients with orthostatic intolerance // J Clin Neurophysiol 2006; 23: 476 -81.
58. Raj SR, Black BK, Biaggioni I et al. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome // Circulation 2005; 111: 2734-40.
59. Ewan V, Norton M, Newton JL. Symptom improvement in postural orthostatic tachycardia syndrome with the sinus node blocker ivabradine // Europace 2007; 9: 1202.
60. Hoeldtke RD, Bryner KD, Hoeldtke ME, Hobbs G. Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR // Clin Auton Res 2007; 17: 334-40.
61. Jandeleit K, Heintz B, Gross-Heitfeld E et al. Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietin // Nephron 1990; 56: 220-1.
62. Biaggioni I, Robertson D, Krantz S et al. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin // Ann Intern Med 1994; 121: 181 -6.
63. Hoeldtke RD, Horvath GG, Bryner KD. Treatment of orthostatic tachycardia with erythropoietin // Am J Med 1995; 99: 525-9.
64. Grubb BP, Samoil D, Kosinski D et al. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension // Am J Med 1994; 97: 366 -8.
65. Di Girolamo E, Di Iorio C, Sabatini P et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study // J Am Coll Cardiol 1999; 33: 1227-30.
66. Grubb BP, Karas BJ. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances // J Interv Card Electrophysiol 1998; 2: 325-32.
67. Johnson EM, Whyte E, Mulsant BH et al.Cardiovascular changes associated with venlafaxine in the treatment of late-life depression // Am J Geriatr Psychiatry 2006; 14: 796-802.
68. Schroeder C, Birkenfeld AL, Mayer AF et al. Norepinephrine transporter inhibition prevents tilt-induced presyncope // J Am Coll Cardiol 2006; 48: 516 -22.
69. Schroeder C, Tank J, Boschmann M et al. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance // Circulation2002; 105: 347 -53.
70. Grubb BP, Kosinski D, Mouhaffel A, Pothoulakis A. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope // Pacing Clin Electrophysiol 1996; 19: 836-40.
Рецензия
Для цитирования:
Дупляков Д.В., Горбачева О.В., Головина Г.А. СИНДРОМ ПОСТУРАЛЬНОЙ ОРТОСТАТИЧЕСКОЙ ТАХИКАРДИИ. Вестник аритмологии. 2011;66(66):50-55.
For citation:
Duplyakov D.V., Gorbacheva O.V., Golovina G.A. POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME. Journal of Arrhythmology. 2011;66(66):50-55. (In Russ.)